An adjunct microbiome therapy to enhance immunotherapy efficacy in melanoma patients
Genes Immun
.
2024 Feb;25(1):87-88.
doi: 10.1038/s41435-023-00240-9.
Epub 2023 Dec 13.
Authors
John G Lenehan
1
2
,
Saman Maleki Vareki
3
4
5
6
Affiliations
1
Department of Oncology, Western University, London, ON, Canada.
2
Lawson Health Research Institute, London, ON, Canada.
3
Department of Oncology, Western University, London, ON, Canada. saman.malekivareki@lhsc.on.ca.
4
Lawson Health Research Institute, London, ON, Canada. saman.malekivareki@lhsc.on.ca.
5
Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada. saman.malekivareki@lhsc.on.ca.
6
Ontario Institute of Cancer Research, Toronto, ON, Canada. saman.malekivareki@lhsc.on.ca.
PMID:
38092886
DOI:
10.1038/s41435-023-00240-9
No abstract available
MeSH terms
Humans
Immunotherapy
Melanoma* / therapy
Microbiota*